HRP960063B1 - Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them - Google Patents
Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing themInfo
- Publication number
- HRP960063B1 HRP960063B1 HR960063A HRP960063A HRP960063B1 HR P960063 B1 HRP960063 B1 HR P960063B1 HR 960063 A HR960063 A HR 960063A HR P960063 A HRP960063 A HR P960063A HR P960063 B1 HRP960063 B1 HR P960063B1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutical preparations
- thioureas
- preparation
- production
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19504379A DE19504379A1 (de) | 1995-02-10 | 1995-02-10 | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP960063A2 HRP960063A2 (en) | 1997-10-31 |
HRP960063B1 true HRP960063B1 (en) | 2001-08-31 |
Family
ID=7753608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR960063A HRP960063B1 (en) | 1995-02-10 | 1996-02-08 | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them |
Country Status (30)
Country | Link |
---|---|
US (1) | US5607976A (hr) |
EP (1) | EP0726250B1 (hr) |
JP (1) | JP3774773B2 (hr) |
KR (1) | KR100446565B1 (hr) |
CN (1) | CN1064041C (hr) |
AR (1) | AR001082A1 (hr) |
AT (1) | ATE197291T1 (hr) |
AU (1) | AU700883B2 (hr) |
BR (1) | BR9600370A (hr) |
CA (1) | CA2169219C (hr) |
CZ (1) | CZ290809B6 (hr) |
DE (2) | DE19504379A1 (hr) |
DK (1) | DK0726250T3 (hr) |
ES (1) | ES2152440T3 (hr) |
FI (1) | FI120394B (hr) |
GR (1) | GR3034886T3 (hr) |
HR (1) | HRP960063B1 (hr) |
HU (1) | HU224211B1 (hr) |
IL (1) | IL117078A (hr) |
MY (1) | MY114693A (hr) |
NO (1) | NO305750B1 (hr) |
NZ (1) | NZ280954A (hr) |
PL (1) | PL181656B1 (hr) |
PT (1) | PT726250E (hr) |
RU (1) | RU2155750C2 (hr) |
SI (1) | SI9600040B (hr) |
SK (1) | SK281357B6 (hr) |
TR (1) | TR199600747A2 (hr) |
TW (1) | TW419457B (hr) |
ZA (1) | ZA961050B (hr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19832009A1 (de) | 1998-07-16 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate |
DE19858253A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
DE10060809A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker |
DE10129704A1 (de) * | 2001-06-22 | 2003-01-02 | Aventis Pharma Gmbh | Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks |
CN1330630C (zh) * | 2004-03-10 | 2007-08-08 | 中国药科大学 | 新的磺酰(硫)脲衍生物、其制备方法及含有它们的药物组合物 |
UA87854C2 (en) * | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
MX2008013238A (es) * | 2006-04-12 | 2008-10-21 | Merck & Co Inc | Antagonistas de los canales de calcio de tipo t de piridil amida. |
JP5524071B2 (ja) * | 2007-10-24 | 2014-06-18 | メルク・シャープ・アンド・ドーム・コーポレーション | 複素環フェニルアミドt型カルシウムチャネルアンタゴニスト |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE243821C (hr) * | ||||
DE1493672C3 (de) * | 1964-08-01 | 1974-05-02 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
DE1518874C3 (de) * | 1964-10-07 | 1975-03-13 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
DE1443919C3 (de) * | 1964-12-28 | 1973-11-29 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe, Ver fahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitun gen |
US3917690A (en) * | 1966-11-29 | 1975-11-04 | Hoechst Ag | Benzenesulfonyl ureas and process for their manufacture |
DE1568648C3 (de) * | 1966-12-19 | 1975-03-27 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
BE754454A (fr) * | 1969-08-06 | 1971-02-05 | Bayer Ag | Nouveaux composes hypoglycemiques du type d'arylsulfonylurees et d'arylsulfonylsemicarbazides contenant des groupes carbonamide |
DE2413514C3 (de) * | 1974-03-21 | 1982-03-04 | Hoechst Ag, 6000 Frankfurt | N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung |
DE3011153A1 (de) * | 1980-03-22 | 1981-10-15 | Hoechst Ag, 6000 Frankfurt | Verwendung von n-(4- spitze klammer auf 2-(5-chlor-2-methoxy-benzamido)-aethylspitze klammer zu -benzolsulfonyl)-n'-methyl-harnstoff |
US5215985A (en) * | 1990-07-20 | 1993-06-01 | E. R. Squibb & Sons, Inc. | Method for treating ischemic insult to neurons employing an ATP-sensitive potassium channel blocker |
ES2098069T3 (es) * | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
-
1995
- 1995-02-10 DE DE19504379A patent/DE19504379A1/de not_active Withdrawn
- 1995-12-29 HU HU9503932A patent/HU224211B1/hu not_active IP Right Cessation
-
1996
- 1996-01-29 PL PL96312531A patent/PL181656B1/pl not_active IP Right Cessation
- 1996-02-05 TW TW085101375A patent/TW419457B/zh not_active IP Right Cessation
- 1996-02-05 AT AT96101585T patent/ATE197291T1/de active
- 1996-02-05 ES ES96101585T patent/ES2152440T3/es not_active Expired - Lifetime
- 1996-02-05 DK DK96101585T patent/DK0726250T3/da active
- 1996-02-05 PT PT96101585T patent/PT726250E/pt unknown
- 1996-02-05 DE DE59606062T patent/DE59606062D1/de not_active Expired - Lifetime
- 1996-02-05 EP EP96101585A patent/EP0726250B1/de not_active Expired - Lifetime
- 1996-02-06 SI SI9600040A patent/SI9600040B/sl not_active IP Right Cessation
- 1996-02-07 CN CN96101370A patent/CN1064041C/zh not_active Expired - Fee Related
- 1996-02-08 AR AR33535596A patent/AR001082A1/es unknown
- 1996-02-08 TR TR96/00102A patent/TR199600747A2/xx unknown
- 1996-02-08 HR HR960063A patent/HRP960063B1/xx not_active IP Right Cessation
- 1996-02-08 FI FI960587A patent/FI120394B/fi not_active IP Right Cessation
- 1996-02-08 CZ CZ1996382A patent/CZ290809B6/cs not_active IP Right Cessation
- 1996-02-08 SK SK175-96A patent/SK281357B6/sk not_active IP Right Cessation
- 1996-02-08 IL IL11707896A patent/IL117078A/xx not_active IP Right Cessation
- 1996-02-08 MY MYPI96000472A patent/MY114693A/en unknown
- 1996-02-08 US US08/598,319 patent/US5607976A/en not_active Expired - Lifetime
- 1996-02-08 NZ NZ280954A patent/NZ280954A/en not_active IP Right Cessation
- 1996-02-08 AU AU44429/96A patent/AU700883B2/en not_active Ceased
- 1996-02-09 CA CA002169219A patent/CA2169219C/en not_active Expired - Fee Related
- 1996-02-09 NO NO960529A patent/NO305750B1/no not_active IP Right Cessation
- 1996-02-09 BR BR9600370A patent/BR9600370A/pt not_active Application Discontinuation
- 1996-02-09 ZA ZA961050A patent/ZA961050B/xx unknown
- 1996-02-09 RU RU96102420/04A patent/RU2155750C2/ru not_active IP Right Cessation
- 1996-02-09 JP JP02392796A patent/JP3774773B2/ja not_active Expired - Fee Related
- 1996-02-10 KR KR1019960003232A patent/KR100446565B1/ko not_active IP Right Cessation
-
2000
- 2000-11-22 GR GR20000402575T patent/GR3034886T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802300A3 (en) | N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
HUP9601529A3 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
AU679663B2 (en) | Dermatological or pharmaceutical composition, preparation process and use | |
EP0729748A4 (en) | METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATION | |
IL117598A (en) | Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9603495A3 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
HUP9602122A2 (en) | Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
CZ58196A3 (en) | Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof | |
AU5229793A (en) | Novel extracts of cucurbita sp., process for their preparation and use in medicaments and in cosmetics | |
HUP9600071A3 (en) | Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
HU9402832D0 (en) | Imidazol-4-yl-piperidine derivatives, process for producing them and pharmaceutical use of them | |
HUP9600876A3 (en) | Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
HUP9602635A3 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU5212093A (en) | Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same | |
HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
CZ92295A3 (en) | Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof | |
CS265391A3 (en) | Novel thienodiazepines, process for their preparation and pharmaceutical comprising them | |
HRP960063B1 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
AU5360890A (en) | Substituted azetidinylisothiazolopyridone derivatives, their preparation and their application as medicinal products | |
GR3035710T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them | |
EP0418020A3 (en) | Cephalosporinderivatives, process for their preparation and pharmaceutical compositions | |
GR3034646T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them | |
HU9503345D0 (en) | Substituted benzoyl-guanidine derivatives, process for producing them their use as medicine and diagnosticum and pharmaceutical composition containing them | |
AU4756693A (en) | 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them | |
PL317397A1 (en) | Novel substituted derivatives of chromanylosulphonylurea and chromanylosulphonylthiourea, method of obtaining them, their application in production of pharmaceutic preparations and pharmaceutic preparation as such |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110204 Year of fee payment: 16 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20120209 |